Literature DB >> 34613877

Comparing statistical methods for detecting and estimating waning efficacy of rotavirus vaccines in developing countries.

Michael Haber1, Jacqueline E Tate2, Benjamin A Lopman2,3, Wenrui Qi1, Kylie E C Ainslie4, Umesh D Parashar2.   

Abstract

INTRODUCTION: Vaccination has significantly reduced morbidity and mortality resulting from rotavirus infection worldwide. However, rotavirus vaccine efficacy (VE) appears to wane over the first 2 years since vaccination, particularly in developing countries. Statistical methods for detecting VE waning and estimating its rate have been used in a few studies, but comparisons of methods for evaluating VE waning have not yet been performed. In this work we present and compare three methods - Durham's method, Tian's method, and time-dependent covariate (TDC) method - based on generalizations of the Cox proportional hazard model.
METHODS: We developed a new stochastic agent-based simulation model to generate data from a hypothetical rotavirus vaccine trial where the protective efficacy of the vaccine may vary over time. Input parameters to the simulation model were obtained from studies on rotavirus infections in four developing countries. We applied each of the methods to four simulated datasets and compared the type-1 error probabilities and the powers of the resulting statistical tests. We also compared estimated and true values of VE over time.
RESULTS: Durham's method had the highest power of detecting true VE waning of the three methods. This method also provided quite accurate estimates of VE in each period and of the per-period drop in VE.
CONCLUSIONS: Durham's method is somewhat more powerful than the other two Cox proportional hazards model-based methods for detecting VE waning and provides more information about the temporal behavior of VE.

Entities:  

Keywords:  Cox regression model; agent-based simulations; hazard of infection; rotavirus vaccine; waning vaccine efficacy

Mesh:

Substances:

Year:  2021        PMID: 34613877      PMCID: PMC8828126          DOI: 10.1080/21645515.2021.1968738

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  6 in total

1.  Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.

Authors:  L K Durham; I M Longini; M E Halloran; J D Clemens; A Nizam; M Rao
Journal:  Am J Epidemiol       Date:  1998-05-15       Impact factor: 4.897

2.  Quantifying the Impact of Natural Immunity on Rotavirus Vaccine Efficacy Estimates: A Clinical Trial in Dhaka, Bangladesh (PROVIDE) and a Simulation Study.

Authors:  Elizabeth T Rogawski; James A Platts-Mills; E Ross Colgate; Rashidul Haque; K Zaman; William A Petri; Beth D Kirkpatrick
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

3.  Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies.

Authors:  P G Smith; L C Rodrigues; P E Fine
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

4.  Rotavirus Infection and Disease in a Multisite Birth Cohort: Results From the MAL-ED Study.

Authors:  Venkata Raghava Mohan; Ramanujam Karthikeyan; Sudhir Babji; Monica McGrath; Sanjaya Shrestha; Jasmin Shrestha; Estomih Mdumah; Caroline Amour; Amidou Samie; Emanuel Nyathi; Rashidul Haque; Shahida Qureshi; Pablo Peñataro Yori; Aldo A M Lima; Ladaporn Bodhidatta; Erling Svensen; Pascal Bessong; Tahmeed Ahmed; Jessica C Seidman; Anita K M Zaidi; Margaret N Kosek; Richard L Guerrant; Jean Gratz; James A Platts-Mills; Dennis R Lang; Michael Gottlieb; Eric R Houpt; Gagandeep Kang
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

5.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

6.  Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.

Authors:  Andrew Clark; Kevin van Zandvoort; Stefan Flasche; Colin Sanderson; Julie Bines; Jacqueline Tate; Umesh Parashar; Mark Jit
Journal:  Lancet Infect Dis       Date:  2019-06-06       Impact factor: 25.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.